Critical Reviews in Oncology / Hematology
Volume 73, Issue 1 , Pages 23-30 , January 2010

Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer

  • Sandro Pignata

      Affiliations

    • Medical Oncology, National Cancer Institute, Naples, Italy
    • Corresponding Author InformationCorresponding author at: Instituto Nazionale Tumori de Napoli, Dipartimento Uro-Ginecologico, UOC Oncologia Medica, via M Semmola, Naples, 80131, Italy. Tel.: +39 081 5903637; fax: +39 081 5903861.
    • ,
  • Eric Pujade Lauraine

      Affiliations

    • Medical Oncology, Paris Descartes, AP-HP, Hôtel-Dieu, Paris, France
    • ,
  • Andreas du Bois

      Affiliations

    • Gynecology and Gynecologic Oncology, HSK, Dr. Horst Schmidt Klinik, Wiesbaden, Germany
    • ,
  • Carmela Pisano

      Affiliations

    • Medical Oncology, National Cancer Institute, Naples, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(09)00176-0

doi: 10.1016/j.critrevonc.2009.08.004

Critical Reviews in Oncology / Hematology
Volume 73, Issue 1 , Pages 23-30 , January 2010

Article Tools

* Image Usage & Resolution